MedTrace Logo

Iron Overload in Pediatric Oncology Patients

NCT01034072 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2018-04-11

No results posted yet for this study

Summary

The purpose of this study is to evaluate for iron overload in pediatric oncology and transplant patients who have completed their treatment between one to ten years ago.

Conditions

  • Iron Overload

Sponsors & Collaborators

  • Novartis

    collaborator INDUSTRY

  • Northwell Health

    lead OTHER

Principal Investigators

  • Jonathan Fish, MD · Feinstein Institute for Medical Research

Eligibility

Min Age
78 Months
Max Age
25 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-12-31
Primary Completion
2012-01-31
Completion
2012-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01034072 on ClinicalTrials.gov